Playback speed
10 seconds
Targeted & Immunotherapy for Esophageal Cancer: Are We There Yet? Is Immune Checkpoint Inhibition Without Chemotherapy a First-Line Option for PD-L1 Expressive Tumors With High CPS?
101 views
June 25, 2021
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY